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ABSTRAK 
 
Mielofibrosis adalah sejenis penyakit mieloproliferatif kronik yang dicirikan dengan 
pembengkakan limpa, anemia leukoeritroblastik, poikilositosis berbentuk air-mata (tear-
drop poikilocytosis) dan fibrosis sumsum tulang. Pembedahan splenektomi dilakukan 
untuk pesakit yang memerlukan transfusi darah yang kerap ataupun pembengkakan limpa 
yang amat besar sehingga mengakibatkan gejala-gejala yang memilukan serta 
trombositopenia yang teruk akibat  hipersplenisma.  
Seorang wanita berumur 56 tahun telah didiagnos menghidap penyakit mielofibrosis 
primer pada tahun 2000 dan dirujuk ke Hospital UKM untuk rawatan selanjutnya bagi 
kekerapan transfusi darah yang semakin  meningkat dan juga kerana pembengkakan 
limpanya yang teruk. Beliau juga telah mengalami kolesistitis akut sebanyak dua kali pada 
masa yang lampau. Pemeriksaan menunjukkan paras hemoglobin 6.4g/dl, kiraan sel darah 
putih : 23.4x109/l, kiraan platelet : 163x109/l dengan gambaran leukoeritroblastik dan 
poikilositosis berbentuk air-mata (tear-drop poikilocytosis) pada filem darah periferi. 
Bacaan alkalin fosfatase neutrofil (Neutrophil alkaline phosphatase NAP score) adalah 
184/100 neutrofil. Ujian ultrasound pada abdomen menunjukkan splenomegali yang teruk, 
dan juga terdapat batu karang pundi hempedu yang multipel. Memandangkan kekerapan 
transfusi darah yang semakin meningkat dan juga gejala splenomegali yang teruk, 
pembedahan splenektomi dan kolesistektomi telah dilakukan. Pemeriksaan filem darah 
periferinya selepas splenektomi menunjukkan penurunan poikilositosis berbentuk air-mata 
(tear-drop poikilocytosis) dan juga kehilangan gambaran leukoeritroblastosis. Kami 
percaya bahawa limpa memainkan peranan yang penting dalam pembentukan 
poikilositosis berbentuk air-mata (tear-drop poikilocytosis) dan leukoeritroblastosis, tetapi 
mekanisma yang terlibat masih tidak jelas. 
  
Kata kunci: mielofibrosis, penurunan poikilositosis berbentuk air-mata dan anemia 
leukoeritroblastik. 
 
 
ABSTRACT 
 
Myelofibrosis is a chronic myeloproliferative disorder characterised by splenomegaly, 
leukoerythroblastic anaemia, tear-drop poikilocytosis and marrow fibrosis. Splenectomy is 
indicated for patients requiring frequent transfusions or massive splenomegaly causing 
distressing symptoms and severe thrombocytopenia secondary to hypersplenism.  
A 56 year-old lady diagnosed to have primary myelofibrosis in year 2000 was referred to 
HUKM for further management of her increasing requirement of blood transfusion and 
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massive splenomegaly. She has had two episodes of acute cholecytitis. Investigations 
done in our hospital showed that her hemoglobin level was 6.4g/dl, white cell count of 
23.4x109/l, platelet count 163x109/l and peripheral blood showing leukoerythroblastic 
picture and tear-drop poikilocytosis. Leukocyte alkaline phosphatase score (NAP) was 
184/100 neutrophils. Ultrasound of the abdomen showed massive splenomegaly with 
multiple gall stones. In view of the frequent transfusion requirements and symptomatic 
massive splenomegaly, splenectomy and cholecystectomy was performed. A review of her 
peripheral blood picture, post-splenectomy, showed marked reduction of the tear-drop 
poikilocytosis and leukoerythroblastosis. We believe that the spleen plays an important role 
in their formation, but the exact mechanism remains unclear. 
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INTRODUCTION 
 
Myelofibrosis is a clonal myeloproliferative 
disease characterised by proliferation of 
predominantly granulocytic and 
megakaryocytic series in the bone marrow, 
associated with marrow fibrosis and 
extramedullary hemopoiesis. Peripheral 
blood dacrocytosis and leukoerythroblastic 
features are characteristic findings of 
myelofibrosis especially at the fibrotic 
stage. The pathogenesis of tear-drop 
poikilocytes and leukoerythroblastosis have 
been attributed to a variety of mechanisms 
from marrow fibrosis, extramedullary 
dyserythropoiesis or to the physical 
difficulties of red cells in traversing the tiny 
sinus wall apertures in the spleen.  
In 1977, DiBella et al had suggested that 
the spleen plays an important role in tear-
drop poikilocytes formation after comparing 
the number of tear drop poikilocytes in 
patients with myelofibrosis before and after 
splenectomy. However, no subsequent 
studies were performed to look into the 
mechanisms involved in the formation of 
tear-drop poikilocytes and leuko-
erythroblastosis. Manoharan et al (1998) 
described the effect of chemotherapy on 
the reduction of the extramedullary 
haemopoiesis and liver and spleen size as 
well as the reduction of tear-drop 
poikilocytes. Indirectly, this finding 
supported the theory that the spleen plays 
an important role in the formation of tear-
drop poikilocytes. In this case report, we 
would like to highlight these peculiar 
findings that give insight to the possible 
mechanisms and the role of the spleen in 
the formation of tear-drop poikilocytosis 
and leukoerythroblastosis in myelofibrosis.  
 
CASE REPORT 
 
A 56 year-old lady was diagnosed to have 
primary myelofibrosis in 1999 in a private 
hospital. She was on regular follow-up with 
that hospital until the year 2002 when she 
was referred to Hospital UKM for the 
management of her increasing requirement 
of blood transfusion and massive 
splenomegaly.  
On physical examination, she was found 
to be afebrile. Her vital signs were normal. 
Examination of the cardiovascular system 
showed that she was in congestive heart 
failure with hepatosplenomegaly (liver 
10cm, spleen 18cm below the costal 
margins). Laboratory investigations 
showed the following results: haemoglobin 
6.7g/dl, WBC 24.6x109/l, platelet 153x109/l. 
Liver and renal profiles were normal, serum 
lactate dehydrogenase was 2425 U/l, 
serum uric acid 648μmol/l. In view of the 
worsening of the disease, she was started 
on low dose Busulphan (1mg daily) and 
was on regular follow-up. In July 2002, she 
developed two episodes of acute 
cholecystitis. Investigations done showed 
that her hemoglobin was 6.4g/dl, white cell 
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Fig. 1A Fig. 1B 
Figure 1(A)is the peripheral blood film of this patient before splenectomy showing 
numerous tear-drop poikilocytes as compared to 1(B) which is the peripheral blood film 
taken after splenectomy demonstrating marked reduction in tear-drop poikilocytes. (Wright 
stain, x 400)  
  
 
count of 23.4x109/l, platelet count 163x109/l 
with leukoerythroblastic picture and tear-
drop poikilocytosis (Fig 1A). Leukocyte 
alkaline phosphatase score (NAP) was 
184/100 neutrophils. Ultrasound of the 
abdomen showed massive splenomegaly 
with multiple gall stones. In view of the 
frequent transfusion requirement and 
symptomatic massive splenomegaly, 
splenectomy and cholecystectomy was 
recommended. Following the operation in 
November 2002, she recovered without 
much complication. Review of her blood 
picture post splenectomy showed 
disappearence of the tear-drop poikilo-
cytosis and post-splenectomy changes (Fig 
1B). On the subsequent follow-ups, 
patient’s peripheral blood films showed 
persistent reduction of the tear-drop 
poikilocytes with appearance of target 
cells, schistocytes, spherocytes and 
persistence of nucleated red cells. 
 
DISCUSSION 
 
Various mechanisms were postulated to be 
involved in the formation of tear-drop 
poikilocytes in myelofibrosis. One of it is 
the ineffective erythropoiesis in the bone 
marrow or extramedullary sites such as the 
liver and the spleen, and the other 
postulated mechanism is that these red 
cells become distorted or fragmented in 
their passage through the myelofibrotic 
marrow or the abnormal splenic channels. 
Leblond and Weed (1975) with their 
scanning electron micrograph observations 
in patients with myelofibrosis had 
concluded that the spleen plays a major 
role in the tear-drop poikilocytes formation. 
Following that, DiBella et al (1977) carried 
out a small study on the effect of 
splenectomy on tear-drop poikilocytosis in 
13 patients with myelofibrosis; they found 
that the average number of tear-drop 
poikilocytes per 1,000 RBCs in the pre-
splenectomy smears was 42 (range, 15 to 
112), compared with 11 tear-drop 
poikilocytes in the post-splenectomy 
smears (range, 6 to 20 )(P = less than 
.001). Based on this fourfold decrease in 
the number of tear-drop poikilocytes post-
splenectomy, they had again concluded 
that the spleen plays an important role in 
the formation of tear-drop poikilocytes. The 
postulated mechanisms in which the 
spleen may play a role in the formation of 
these tear-drop poikilocytes are: (i) the 
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distortion of erythrocytes in their passage 
through the splenic sinusoids; (ii) the 
production of distorted erythrocytes by 
extramedullary sites in the spleen or a 
combination of both. Futher review of the 
literatures did not reveal any other reports 
on the study of mechanisms of how the 
spleen causes tear-drop poikilocytosis.    
Manoharan et al (1988) studied the 
effect of chemotherapy on tear-drop 
poikilocytes and other peripheral blood 
findings in myelofibrosis; the observed 
improvement of haemoglobin levels and 
red cell morphology with decreasing spleen 
size and splenic fibrosis after a course of 
chemotherapy. This study further supports 
the notion that spleen plays an important 
role in the red cell changes in 
myelofibrosis. However, the pathogenesis 
of the formation of tear-drop poikilocytes 
remains unclear. It would be interesting to 
look into the exact mechanism of the 
formation of tear-drop poikilocytes as well 
as leukoerythroblastosis in myelofibrosis.    
In this case, we have highlighted the 
interesting findings of reduction of tear-
drop poikilocytes post-splenectomy and 
reinforced the important role of the spleen 
in the formation of tear-drop poikilocytes in 
myelofibrosis.  
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